NOVEL MARKER FOR MUSCULAR DYSTROPHY

To provide a new biomarker for determination of myopathy including DMD.SOLUTION: One or more blood components selected from the group consisting of guanidino succinic acid and phosphocreatine are used as a biomarker for determining myopathy in a subject, in particular Duchenne muscular dystrophy (DM...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HAYASHI MASAHIRO, NAKAISHI TOMOYUKI, KASAHARA YUKO, OKADA NAOMI
Format:	Patent
Sprache:	eng ; jpn
Schlagworte:	INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING PHYSICS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	To provide a new biomarker for determination of myopathy including DMD.SOLUTION: One or more blood components selected from the group consisting of guanidino succinic acid and phosphocreatine are used as a biomarker for determining myopathy in a subject, in particular Duchenne muscular dystrophy (DMD).SELECTED DRAWING: None 【課題】DMDを含むミオパチーの判定のための新たなバイオマーカーを提供すること。【解決手段】被検体におけるミオパチー、特にデュシェンヌ型筋ジストロフィー（DMD）を判定するための、グアニジノコハク酸及びホスホクレアチンからなる群より選択される1以上の血液成分のバイオマーカーとしての使用。【選択図】なし